Clinical Trial Update: Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating two-generation anti-CEA designer T cells for gastric cancer has been withdrawn. The sponsor is Roger Williams Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 2nd Generation Anti-CEA Designer T Cells

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Gastric Cancer | Phase 1 | Status: WITHDRAWN